AxelrodJ.ShoferInscoe J. R. et coll.: The fate of papaverine in man and other mammals. J. Pharmacol.124 (1958), 9.
2.
BrömsterD.: Gastric emptying rate in gastric and duodenal ulceration. To be published in Scand. J. Gastroenterology.
3.
CarlbergerG.LundhG.: Measurement of gastric emptying rate using 131I-HSA. Scand. J. Gastroenterology3 (1968), 641.
4.
CarlbergerG.LundhG.Et coll.: The effect of some oral anticholinergics on gastric emptying, pH and osmolarity in man. To be published in Scand. J. Gastroenterology.
5.
DaniélopoluD.SimiciD.DimitriuC.: Action de la papavérine sur l'estomac de l'homme. Arch. int. Pharmacodyn.29 (1924), 471.
6.
GaglioM.BlasiA.: Valutazione di effetti farmacodinamici sui movimenti intestinali. Azione della papaverina. (In Italian.) SocItal. Biol. sper.41 (1965), 105.
7.
GötteP.: Erfahrungen mit dem Spasmolytikum Papavydrin bei intravenöser Anwendung. Dtsch. med. Wschr.60 (1934), 409.
8.
HolzknechtG.SgalitzerM.: Pagaverin zur röntgenologischen Differentialdiagnose zwischen Pylorospasmus und Pylorusstenose. Münch. med. Wschr.36 (1913), 1989.
9.
HuntJ. N.SpurrellW. R.: The pattern of emptying of the human stomach. J. Physiol.113 (1951), 157.
10.
KayA. W.: Effect of large doses of histamine on gastric secretion of HCl; an augmented histamine test. Brit. med. J2 (1953), 77.
11.
MachtD. I.: A pharmacologic and clinical study of papaverine. Arch. intern. Med. (1916), 786.
12.
MöllerJ.RosénA.: Comparative studies on intramuscular and oral effective doses of some anticholinergic drugs. Acta med. Scand.184 (1968), 201.
13.
ReynoldsA. K.RandallL. O.: Morphine and allied drugs, pp. 196–210. University of Toronto Press, Toronto1957.
14.
RussekH. I.ZohmanB. L.: Papaverine in cerebral angiospasm (vascular encephalopathy). J. Amer. med. Ass.136 (1948), 930.
15.
WrightS.: Applied physiology. Ninth edition, p. 300. Oxford University Press, London1952.